Evidence map›Paper›PMID 26811730›Full record

ArticleIranian journal of parasitology

Efficacy of the Bunium persicum (Boiss) Essential Oil against Acute Toxoplasmosis in Mice Model.

Amir Tavakoli Kareshk, Amir Keyhani, Hossein Mahmoudvand, Razieh Tavakoli Oliaei, Arash Asadi, Moazameh Andishmand, Hossein Azzizian, Zahra Babaei, Naser Zia-Ali

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Potent In Vitro and In Vivo Effects ofTropical medicine and infectious disease · 2023
    Article
  3. The role ofFrontiers in cellular and infection microbiology · 2023
    Article
  4. Article
  5. Potential effects of alpha-pinene, a monoterpene commonly found in essential oils againstJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  6. Nano amphotericin B: a good anti-leishmanial drug with effect on cathelicidin gene expression.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Article
  7. Cytotoxic and Antileishmanial Effects of Various Extracts ofTurkish journal of pharmaceutical sciences · 2021
    Article
  8. Frontiers in cell and developmental biology · 2021
    Article
  9. In vitro and in vivoFood science & nutrition · 2021
    Article
  10. Evaluation ofFrontiers in cellular and infection microbiology · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Annals of medicine and surgery (2012) · 2019
    Article
  16. Review
  17. Pharmacognosy magazine · 2017
    Article
  18. Avicenna journal of phytomedicine
    Article
  19. Efficacy and Safety ofIranian journal of parasitology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Amir Tavakoli KareshkDept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran.
Amir KeyhaniDept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran.
Hossein MahmoudvandResearch Center for Tropical and Infectious Diseases, Kerman University of Medical Science, Kerman, Iran.
Razieh Tavakoli OliaeiDept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran.
Arash AsadiDept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran.
Moazameh AndishmandDept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran.
Hossein AzzizianDepartment of Physiology, Kerman University of Medical Sciences, Kerman, Iran.
Zahra BabaeiDept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran.
Naser Zia-AliDept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran.
Kerman University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe evaluated the in vivo activity of Bunium persicum (Boiss) essential oil on infected mice with acute toxoplasmosis.

methodsTo evaluate prophylactic effects, male NMRI mice received B. persicum essential oil at the concentrations of 0.05 and 0.1 mL/kg for 14 days. After 24 h mice were infected intraperitonealy with 1×10(4) tachyzoites of T. gondii, RH strain. In order to investigate therapeutic effects, mice were infected and then received B. persicum oil at the concentrations of 0.05 and 0.1 ml/kg two times a day for 5 days. The time/mean time of death in all infected mice and the number of tachyzoites from infected mice were recorded.

resultsThe time/mean time of death of infected mice was 8 and 9 days after oral administration of B. persicum oil at the concentration of 0.05 and 0.1 mL/kg, respectively (P<0.05). In contrast, the time/mean time of death control group was 5 days. In addition, B. persicum significantly reduced the mean number of tachyzoites compared with control group. The time/mean time of death of infected mice was 6 and 7 days after oral administration of B. persicum essential oil at the concentration of 0.05 and 0.1 mL/kg, respectively. In contrast, the time/mean time of death control group was 5 days. B. persicum especially at the concentration of 0.1 ml/kg significantly reduced the mean number of tachyzoites compared with control group.

conclusionThe results showed the potential of B. persicum essential oil as a natural source for the production of new prophylactic agent for use in toxoplasmosis.

Indexed as

Bunium persicum BoissProphylacticTherapeuticToxoplasma gondii

Identifiers

PMID26811730
PMCPMC4724840
OpenAlexW2221890562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.